🎙️ This Week in Pharmacy – Friday, December 5th

Strengthening the Pharmacy Workforce: A Conversation with Crystal Lennartz
Cutting Through the AI Confusion: Shaun Jensen on Smarter Pharmacy Operations
The New 340B Reality: Allison Arant on Navigating HRSA’s Rebate Model

Welcome to another episode of This Week in Pharmacy, where we bring together the most important conversations, industry insights, and breaking pharmacy news shaping the future of healthcare. Today’s show features a powerhouse lineup of leaders driving innovation across retail pharmacy, technology, consulting, and 340B health-system strategy.

🟦 Segment 1 — Interview with Crystal Lennartz, President of Health Mart & Health Mart Atlas

We open the show with a conversation with Crystal Lennartz, President of Health Mart and Health Mart Atlas, about the evolving role of workforce management in independent pharmacies. 

📰 TWIRx News — Friday, December 5th
A fast roundup of the top stories impacting pharmacy this week:


👉 Humana Exploring Partnership with Mark Cuban
Humana is reportedly in discussions with Mark Cuban to explore a potential pharmacy partnership that could disrupt traditional PBM and drug-supply models. The collaboration may reshape how medications are priced and accessed—another sign that alternative pharmacy models are gaining traction.


👉 New Migraine Therapy: Symbravo
Pharmacists should be aware of Symbravo, a new dual-action migraine therapy combining meloxicam and rizatriptan. Importantly, the product is non-substitutable, meaning pharmacies must dispense exactly as written. The therapy adds a new tool for acute migraine care but requires careful patient counseling on cardiovascular risks, medication-overuse headaches, and NSAID interactions.


👉 Walgreens Expands Automated Fulfillment Centers
Walgreens continues restructuring by expanding its automated micro-fulfillment pharmacy network. Robots are now filling a growing percentage of maintenance prescriptions, allowing pharmacists to refocus on clinical services. The move signals accelerating automation across retail pharmacy as chains seek cost savings and operational efficiency.



🟦 Segment 2 — Interview with Shaun Jensen, CEO of JB Consulting Group

Next, we speak with Shaun Jensen, CEO of JB Consulting Group, about the rising confusion many pharmacy operators face around AI adoption.
We discuss:


<ul>
<li>Where AI adds true efficiency versus where it’s misunderstood</li>
<li>Practical steps for pharmacy owners to implement AI tools</li>
<li>How data-driven automation can improve workflow, inventory, prior authorizations, and patient communication</li>
<li>The mindset shift required for pharmacies to thrive in an AI-supported future

</li>
</ul>
🟦 Segment 3 — Interview with Allison Arant, SVP of Client Development & Marketing, Clearway Health

Our final interview is with Allison Arant from Clearway Health, focusing on the new challenges hospital systems face as HRSA launches the 340B rebate model.
Key discussion points:
<ul>
<li>How the rebate model changes operational and financial dynamics for 340B hospitals</li>
<li>Why safety-net hospitals caring for large uninsured and underinsured populations are feeling heightened pressure</li>
<li>Strategies Clearway Health is deploying to help health systems navigate rising medication costs, compliance demands, and shrinking margins</li>
<li>What health-system pharmacies must prepare for heading into 2026

</li>
</ul>
This week’s conversations underscored a unifying theme: the pharmacy industry is entering a period of rapid transformation, driven by new reimbursement models, automation, innovation partnerships, and evolving expectations from both patients and payers. Independent pharmacies, health systems, and specialty operators all face challenges—but also significant opportunities for reinvention, collaboration, and leadership.


Thank you for tuning in to This Week in Pharmacy. Stay informed, stay inspired, and keep pushing our profession forward.
 
Walgreens doubles down on automation to reshape pharmacy operations. The retail pharmacy giant is dramatically expanding its network of robot-powered micro-fulfillment centers (MFCs) — facilities that dispense maintenance medications for chronic conditions like diabetes and hypertension. The goal: serve 5,000+ stores by the end of the year, up from earlier coverage of around 4,800 stores.
<a href='https://chainstoreage.com/news-briefs/2025-12-05?article=walgreens-expands-automated-pharmacy-fulfillment-network'>https://chainstoreage.com/news-briefs/2025-12-05?article=walgreens-expands-automated-pharmacy-fulfillment-network
</a>
New migraine therapy raises key practice questions for pharmacists. Symbravo — a fixed-dose oral tablet combining meloxicam (an NSAID) and rizatriptan (a triptan) — has been approved for the acute treatment of migraine with or without aura, offering a dual-mechanism option targeting both inflammation and serotonin-mediated pathways. 


Pharmacists now play a critical role: they must identify patients at risk for medication-overuse headaches, screen for contraindications (e.g., cardiovascular disease, GI risk, or NSAID/triptan interactions), and advocate for comprehensive migraine management beyond just pain relief — including lifestyle adjustments and referrals when needed.
<a href='https://www.pharmacytimes.com/view/what-pharmacists-should-know-about-symbravo-s-role-and-non-substitutability-in-migraine-care'>https://www.pharmacytimes.com/view/what-pharmacists-should-know-about-symbravo-s-role-and-non-substitutability-in-migraine-care</a>






Humana is reportedly working with Mark Cuban on a potential pharmacy partnership — a development that could shake up how prescriptions are delivered and disrupt traditional middle-man models. 

The collaboration would leverage Cuban’s innovative approach to drug pricing and distribution, potentially creating a new channel for medication access that bypasses traditional pharmacy benefit managers (PBMs) and large-chain dispensaries. If executed, the partnership could increase competitive pressure on legacy players and reshape the pharmacy supply chain. 


For independent pharmacies and pharmacy leaders, this signals a possible shift in how drugs are sourced, priced, and distributed — highlighting the growing influence of alternative pharmacy models and urging traditional pharmacies to adapt or risk being left behind.
<a href='https://www.bloomberg.com/news/articles/2025-12-04/humana-working-with-mark-cuban-on-potential-pharmacy-partnership'>https://www.bloomberg.com/news/articles/2025-12-04/humana-working-with-mark-cuban-on-potential-pharmacy-partnership

</a>




Washington, DC there's a whole bunch of pharmacy people meeting up to rollout the Pharmacists Fight Back Act (PFBA)! If you want to go, LISTEN UP!! You’ll be joining pharmacists and pharmacy owners from more than 17 states, all calling for meaningful pharmacy reimbursement reform NOW. Your presence at the news conference will send a strong message to your Congressional Delegate: "we’re serious about passing legislation that protects and keeps pharmacies in business." 


The news conference is scheduled for Thursday, December 11th at 9:30 AM on the Capitol Hill lawn. Meet up with "Pharmacists United for Truth and Transparency".   Check out TRUTH RX dot org. We put a link in today's show notes. Check it out or reach out to Todd on LinkedIn.
<a href='http://www.truthrx.org/'>TruthRx.org </a>







 


The New Pharmacy Playbook: Workforce Strength, AI Clarity, and 340B Reform | TWIRx

Podurama

Home

Trending

Personal

Your Podcasts

New Episodes

My Files

Favourite Episodes

Tags (Folders)

Recently Played

Bookmarks

Followed Playlists

The New Pharmacy Playbook: Workforce Strength, AI Clarity, and 340B Reform | TWIRx

Pharmacy Podcast Network

AI Chapters

AI Insights

Reviews